Educational content on VJRegenMed is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

Advanced Therapies Week 2022 | The future of small-diameter human acellular vessels

Whilst the field of cardiac bioengineering has predominantly focused on 3D printing and cell and gene therapies, research on human acellular vessels (HAVs) is still in its infancy. Alan Kypson, MD, FACS, UNC REX Hospital, Raleigh, NC, discusses current developments in HAVs and their potential applications. Large-diameter HAVs can be applied in dialysis for patients with end-stage renal disease or in a surgical setting for patients with peripheral arterial disease (PAD). Dr Kypson additionally emphasizes future research on small-diameter HAVs, which can be used in patients with cardiovascular disease, especially in patients who often lack the appropriate vessels for bypass surgery. This interview took place at Advanced Therapies Week 2022.